georgejjl
30 minutes ago
"...Cognision, providers of advanced neurobiomarker technology, announces its partnership with Anavex Life Sciences Corp. (Nasdaq: AVXL), in a phase 2 clinical trial of ANAVEX®3-71 in subjects with schizophrenia.
ANAVEX®3-71 is a therapeutic agent with a dual mecha